Caron A. Jacobson, MD, and Miguel-Angel Perales, MD, discuss different uses for CAR T-cell therapy, particularly a trial in which a CAR T-Cell therapy is being evaluated in MRD-positive patients treated with chemotherapy.
Weighing the Benefits and Limitations of CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
Revisit the OncLive On Air Episodes From February 2024
Eckfeldt Looks Towards the Future of AML and MDS Care
Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma
Neelapu Highlights the Nuances of CAR T-Cell Therapy Administration in Lymphoma
WU-CART-007 Receives FDA RMAT and EMA PRIME Designations for R/R T-ALL and T-LBL
Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma
Prospective Data Reveal Most Young Survivors of Breast Cancer Could Successfully Give Birth
HPV Vaccinations Associated With Lower Rates of HPV-Caused Cancers in Patients Under 40 Years of Age
AI Virtual Navigation May Reengage Patients to Undergo Missed Colonoscopies